By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Proteostasis Therapeutics, Inc. 

200 Technology Square
Suite 402
Cambridge  Massachusetts  02139  U.S.A.
Phone: n/a Fax: n/a



Company News
Proteostasis (PTI) Appoints Helen M. Boudreau As Chief Financial Officer 8/1/2017 12:22:48 PM
Proteostasis (PTI) Announces Progression Of PTI-428 And PTI-801 To Longer Duration Studies In CF Subjects 8/1/2017 12:21:39 PM
Proteostasis (PTI) Reports Preliminary Data From Phase I Study Of PTI-428 In Patients With Cystic Fibrosis 6/29/2017 8:25:48 AM
Proteostasis (PTI) Files Investigational New Drug Application For PTI-808, Cystic Fibrosis Potentiator 6/23/2017 8:33:07 AM
Proteostasis (PTI) Announces Clinical And Regulatory Progress Across Pipeline Programs 6/7/2017 8:41:59 AM
Proteostasis (PTI) Reports Fourth Quarter And Year-End 2016 Financial Results And Provides Corporate Update 3/31/2017 10:54:06 AM
Proteostasis (PTI) Reports Third Quarter 2016 Financial Results 11/10/2016 8:49:28 AM
Proteostasis (PTI) Appoints Naimish Patel, M.D., C.M., And Elizabeth Tullis, M.D., FRCPC, To Its Clinical Advisory Board 9/28/2016 7:36:27 AM
Proteostasis (PTI) Announces Scientific Presentations On New Data At 30th Annual North American Cystic Fibrosis Conference 9/22/2016 10:13:23 AM
Proteostasis (PTI) To Present At Upcoming Investor Conferences 9/16/2016 8:02:22 AM